Terms: = Lymphoma AND PTPRK, DKFZp686C2268, 5796, ENSG00000152894, DKFZp779N1045, R-PTP-kappa, RP3-480J14_1
72019 results:
1. Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing.
Lahey KC; Varsanyi C; Wang Z; Aquib A; Gadiyar V; Rodrigues AA; Pulica R; Desind S; Davra V; Calianese DC; Liu D; Cho JH; Kotenko SV; De Lorenzo MS; Birge RB
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673989
[TBL] [Abstract] [Full Text] [Related]
2. Serum Levels of miR-122-5p and miR-125a-5p Predict Hepatotoxicity Occurrence in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Mikulski D; Kościelny K; Dróżdż I; Mirocha G; Nowicki M; Misiewicz M; Perdas E; Strzałka P; Wierzbowska A; Fendler W
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673940
[TBL] [Abstract] [Full Text] [Related]
3. TANK Binding Kinase 1 Promotes BACH1 Degradation through Both Phosphorylation-Dependent and -Independent Mechanisms without Relying on Heme and FBXO22.
Liu L; Matsumoto M; Watanabe-Matsui M; Nakagawa T; Nagasawa Y; Pang J; Callens BKK; Muto A; Ochiai K; Takekawa H; Alam M; Nishizawa H; Shirouzu M; Shima H; Nakayama K; Igarashi K
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673728
[TBL] [Abstract] [Full Text] [Related]
4. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin lymphoma Cell Lines.
Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
[TBL] [Abstract] [Full Text] [Related]
6. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
[TBL] [Abstract] [Full Text] [Related]
7. Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center.
Hao Z; Fei Y; Chen J; Huang S; Wang L; Yu Y; Bian M; Si Y; Zhang X; Yang X; Zhang B; Wan Y; Zhang Y; Lin G
Hematology; 2024 Dec; 29(1):2344998. PubMed ID: 38666535
[TBL] [Abstract] [Full Text] [Related]
8. When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario.
Danesin N; Scapinello G; Del Prete D; Naso E; Berno T; Visentin A; Bonaldi L; Martines A; Bertorelle R; Vianello F; Gurrieri C; Zambello R; Castellani C; Fedrigo M; Rizzo S; Angelini A; Trentin L; Piazza F
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2062. PubMed ID: 38662353
[TBL] [Abstract] [Full Text] [Related]
9. Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia.
Wu X; Cao Z; Chen Z; Wang Y; He H; Xiao P; Hu S; Lu J; Li B
Clin Exp Med; 2024 Apr; 24(1):87. PubMed ID: 38662121
[TBL] [Abstract] [Full Text] [Related]
10. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
11. [Inhibition of Autophagy Augments the Anticancer Activity of KPT-330 in Mantle Cell lymphoma Cells].
Zhang YL; Chen YH; Zheng RJ; Zheng KJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):470-475. PubMed ID: 38660854
[TBL] [Abstract] [Full Text] [Related]
12. [Expression of CD30 in Patients with Diffuse Large B-Cell lymphoma and Clinical Significance].
Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
[TBL] [Abstract] [Full Text] [Related]
13. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's lymphoma].
Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
[TBL] [Abstract] [Full Text] [Related]
14. [A Real-World Single-Center Study of Adult Hodgkin's lymphoma].
Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
[TBL] [Abstract] [Full Text] [Related]
15. [Curcumin Combined with Thalidomide Inhibits Proliferation of KG-1 Cells and Its Related Mechanisms].
Liu J; Huang Y; Liu Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):422-427. PubMed ID: 38660846
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line
Valizadeh Toosi SM; Feyzi S; Kazemi A
Korean J Gastroenterol; 2024 Apr; 83(4):150-156. PubMed ID: 38659251
[TBL] [Abstract] [Full Text] [Related]
17. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
Hu Y; Zhang M; Yang T; Mo Z; Wei G; Jing R; Zhao H; Chen R; Zu C; Gu T; Xiao P; Hong R; Feng J; Fu S; Kong D; Xu H; Cui J; Huang S; Liang B; Yuan X; Cui Q; Guo H; Yu Y; Feng Y; Jin C; Ren J; Chang AH; Wang D; Huang H
N Engl J Med; 2024 Apr; 390(16):1467-1480. PubMed ID: 38657244
[TBL] [Abstract] [Full Text] [Related]
18. XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.
Chakravarti N; Boles A; Burzinski R; Sindaco P; Isabelle C; McConnell K; Mishra A; Porcu P
Sci Rep; 2024 Apr; 14(1):9305. PubMed ID: 38653804
[TBL] [Abstract] [Full Text] [Related]
19. Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.
Popov A; Henze G; Tsaur G; Budanov O; Roumiantseva J; Belevtsev M; Verzhbitskaya T; Movchan L; Lagoyko S; Zharikova L; Olshanskaya Y; Riger T; Valochnik A; Miakova N; Litvinov D; Khlebnikova O; Streneva O; Stolyarova E; Ponomareva N; Novichkova G; Aleinikova O; Fechina L; Karachunskiy A
Cancer Med; 2024 Apr; 13(8):e7172. PubMed ID: 38651186
[TBL] [Abstract] [Full Text] [Related]
20. Conventional and novel [
Leithner D; Flynn JR; Devlin SM; Mauguen A; Fei T; Zeng S; Zheng J; Imber BS; Hubbeling H; Mayerhoefer ME; Bedmutha A; Luttwak E; Corona M; Dahi PB; Luna de Abia A; Landego I; Lin RJ; Palomba ML; Scordo M; Park JH; Tomas AA; Salles G; Lafontaine D; Michaud L; Shah GL; Perales MA; Shouval R; Schöder H
J Hematol Oncol; 2024 Apr; 17(1):21. PubMed ID: 38649972
[TBL] [Abstract] [Full Text] [Related]
[Next]
